Calcitonin Gene-Related Peptide
"Calcitonin Gene-Related Peptide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
| Descriptor ID |
D015740
|
| MeSH Number(s) |
D12.644.400.097 D12.776.631.650.097
|
| Concept/Terms |
Calcitonin Gene-Related Peptide- Calcitonin Gene-Related Peptide
- Calcitonin Gene Related Peptide
- Gene-Related Peptide, Calcitonin
- Peptide, Calcitonin Gene-Related
|
Below are MeSH descriptors whose meaning is more general than "Calcitonin Gene-Related Peptide".
Below are MeSH descriptors whose meaning is more specific than "Calcitonin Gene-Related Peptide".
This graph shows the total number of publications written about "Calcitonin Gene-Related Peptide" by people in this website by year, and whether "Calcitonin Gene-Related Peptide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 7 | 5 | 12 |
| 2018 | 2 | 5 | 7 |
| 2019 | 7 | 3 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Calcitonin Gene-Related Peptide" by people in Profiles.
-
A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection. Clin Chem Lab Med. 2019 Sep 25; 57(10):1638-1646.
-
Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain. Cephalalgia. 2019 Dec; 39(14):1827-1837.
-
Fremanezumab for the preventive treatment of migraine in adults. Expert Rev Clin Pharmacol. 2019 Aug; 12(8):741-748.
-
Optimising migraine treatment: from drug-drug interactions to personalized medicine. J Headache Pain. 2019 May 17; 20(1):56.
-
Anti-CGRP in cluster headache therapy. Neurol Sci. 2019 May; 40(Suppl 1):129-135.
-
CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA. J Headache Pain. 2019 Apr 23; 20(1):39.
-
Fremanezumab for the prevention of chronic and episodic migraine. Drugs Today (Barc). 2019 Apr; 55(4):265-276.
-
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? J Headache Pain. 2019 Mar 12; 20(1):27.
-
[Overexpression of CGRP improves peripheral neuropathy in diabetic mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Mar; 35(3):250-255.
-
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019 Jan 16; 20(1):6.